Sacroiliac joint arthrodesis implant
Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
Public Assessment Report
(PAR)
01-12-2017
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Available from:
Emergo Asia Pacific Pty Ltd T/a Emergo Australia
Class:
Class IIb
Manufactured by:
Signus Medizintechnik GmbH Industriestrasse 2, Alzenau, D-63755 Germany
Therapeutic area:
58733 - Sacroiliac joint arthrodesis implant
Therapeutic indications:
A sacroiliac fusion implant for stabilisation of the sacroiliac joint. This implantation is performed through a posterior approach. The device is indicated for painful sacroiliac joints in skeletally mature patients, requiring surgical stabilisation by bone grafting and internal fixation.
Authorization status:
A
Authorization date:
2013-10-31
